30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

TREU JESSE I

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
TREU JESSE I's trades of Aldeyra Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-03-28 2019-03-26
S Sale
68,620 +17.9%
336.38
US$4,000,329 		68,620 +17.9% 336.38 US$4,000,329
2019-03-28 2019-03-26
S Sale
77,948 +5.3%
409.44
US$1,853,727 		77,948 +5.3% 409.44 US$1,853,727
2019-03-04 2019-03-04
US Veracyte Inc (VCYT)
S Sale
56,734 -23.0%
74.69
US$207,364 		56,734 -23.0% 74.69 US$207,364
2019-03-04 2019-03-04
US Veracyte Inc (VCYT)
S Sale
414,958 -25.2%
20.21
US$8,386,301 		414,958 -25.2% 20.21 US$8,386,301
2019-03-04 2019-03-01
US Veracyte Inc (VCYT)
S Sale
2,023 -14.2%
20.45
US$41,370 		2,023 -14.2% 20.45 US$41,370
2019-03-04 2019-03-01
US Veracyte Inc (VCYT)
S Sale
272,977 -14.2%
20.45
US$5,582,380 		272,977 -14.2% 20.45 US$5,582,380
2019-03-04 2019-02-28
US Veracyte Inc (VCYT)
S Sale
207 -1.4%
21.24
US$4,397 		207 -1.4% 21.24 US$4,397
2019-03-04 2019-02-28
US Veracyte Inc (VCYT)
S Sale
27,793 -1.4%
21.24
US$590,323 		27,793 -1.4% 21.24 US$590,323
2019-03-04 2019-02-28
US Veracyte Inc (VCYT)
S Sale
2,381 -14.2%
20.44
US$48,668 		2,381 -14.2% 20.44 US$48,668
2019-03-04 2019-02-28
US Veracyte Inc (VCYT)
S Sale
319,619 -14.1%
20.44
US$6,533,012 		319,619 -14.1% 20.44 US$6,533,012